University of Suceava, Faculty of Food Engineering, Suceava, Romania.
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2013;48(3):251-62. doi: 10.1080/10934529.2013.726805.
In this study a comparative assessment using various advanced oxidation processes (UV/H(2)O(2), UV/H(2)O(2)/Fe(II), O(3), O(3)/UV, O(3)/UV/H(2)O(2) and O(3)/UV/H(2)O(2)/Fe(II)) was attempted to degrade efficiently two fluoroquinolone drugs ENR [enrofloxacin (1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolonecarboxylic acid)] and CIP [ciprofloxacin (1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid)] in aqueous solutions at a concentrations of 0.15 mM for each drug. The efficiency of the applied oxidation processes (AOPs) has been estimated by the conversion of the original substrate (X(ENR) and X(CIP)) and the reduction of chemical oxygen demand (COD), total organic carbon (TOC). Special emphasis was laid on the effect of varying reaction pH as well as of the applied oxidant doses on the observed reaction kinetics for each advanced oxidation processes. High degradation efficiencies, particularly in terms of rates of TOC and COD abatement, were obtained for photo-Fenton assisted ozonation [O(3)/UV/H(2)O(2)/Fe(II)], compared to other advanced oxidation processes. At pH 3 and 25°C best results for the degradation of both investigated drugs were achieved when 10 mM H(2)O(2), 0.5 mM Fe(II) and an initial dose of 8.5 mg L(-1) ozone were applied. In addition, the evolution of toxicity of the reaction mixtures for different AOPs has been studied by the bioluminescence test (LUMIStox 300).
在这项研究中,尝试使用各种高级氧化工艺(UV/H(2)O(2)、UV/H(2)O(2)/Fe(II)、O(3)、O(3)/UV、O(3)/UV/H(2)O(2)和 O(3)/UV/H(2)O(2)/Fe(II))对两种氟喹诺酮药物 ENR[恩诺沙星(1-环丙基-7-(4-乙基-1-哌嗪基)-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸)]和 CIP[环丙沙星(1-环丙基-6-氟-4-氧代-7-(哌嗪-1-基)-喹啉-3-羧酸)]进行有效降解,两种药物在水溶液中的浓度均为 0.15mM。通过原始底物(X(ENR) 和 X(CIP))的转化率和化学需氧量(COD)、总有机碳(TOC)的减少来评估应用氧化工艺(AOPs)的效率。特别强调了反应 pH 值以及应用氧化剂剂量对每种高级氧化工艺观察到的反应动力学的影响。与其他高级氧化工艺相比,光芬顿辅助臭氧氧化[O(3)/UV/H(2)O(2)/Fe(II)]在去除 TOC 和 COD 方面具有较高的降解效率,特别是在速率方面。在 pH 3 和 25°C 时,当应用 10mM H(2)O(2)、0.5mM Fe(II)和初始臭氧剂量 8.5mg L(-1)时,两种研究药物的降解效果最佳。此外,通过生物发光试验(LUMIStox 300)研究了不同 AOPs 反应混合物的毒性演变。